Cargando…
Capecitabine Can Induce T Cell Apoptosis: A Potential Immunosuppressive Agent With Anti-Cancer Effect
Capecitabine (CAP) is now widely used in the comprehensive treatment of digestive system tumors. Some clinical observations have shown that CAP may have immunosuppressive effects, but there is still a lack of clear experimental verification. In this study, different doses of CAP were administered to...
Autores principales: | Zhang, Sai, Wang, Zhenglu, Fan, Shunli, Liu, Tao, Yoshida, Sei, Yang, Shuang, Liu, Lei, Hou, Wen, Cao, Lei, Wang, Jianxi, Song, Zhuolun, Li, Shanni, Zhang, Sirui, Wang, Hao, Li, Jianghong, Zheng, Hong, Shen, Zhongyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452994/ https://www.ncbi.nlm.nih.gov/pubmed/34557199 http://dx.doi.org/10.3389/fimmu.2021.737849 |
Ejemplares similares
-
Capecitabine Regulates HSP90AB1 Expression and Induces Apoptosis via Akt/SMARCC1/AP-1/ROS Axis in T Cells
por: Zhang, Sai, et al.
Publicado: (2022) -
A novel predictive model of microvascular invasion in hepatocellular carcinoma based on differential protein expression
por: Wang, Zhenglu, et al.
Publicado: (2023) -
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients’ T cell ferroptosis
por: Wang, Hao, et al.
Publicado: (2023) -
Nomogram based on spleen volume expansion rate predicts esophagogastric varices bleeding risk in patients with hepatitis B liver cirrhosis
por: Li, Jianghong, et al.
Publicado: (2022) -
Proliferation of human hepatocellular carcinoma cells from surgically resected specimens under conditionally reprogrammed culture
por: Wang, Zhenglu, et al.
Publicado: (2019)